Sign in

CIK 0001531177 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Sight Sciences, Inc.

Sign in to watch
Ticker
SGHT
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
800625749
Phone
(415) 889-0550
Business address
4040 CAMPBELL AVE,, SUITE 100, MENLO PARK, CA, 94025
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$652,777
in 5 filings, $653K under 10b5-1 plans

Net −$652,777. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Badawi Paul −$268K President and CEO sold <1% of stake
  2. Bauerlein Alison −$224K Chief Operating Officer sold 4% of stake
  3. Badawi David −$71K Chief Technology Officer sold <1% of stake
  4. Rodberg James −$64K Chief Financial Officer sold 3% of stake
  5. Taylor Brenton −$26K EVP, Operations & R&D sold 1% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-10-02 Rodberg James Chief Financial Officer Sale 10b5-1 −7,208 $8.85 $64K 216,829
2026-07-02 Rodberg James Chief Financial Officer Sale 10b5-1 −6,902 $5.36 $37K 224,037
2026-04-06 Rodberg James Chief Financial Officer Sale 10b5-1 −7,231 $3.55 $26K 230,939
2026-02-03 Rodberg James Chief Financial Officer Grant or award +86,940 238,170
2026-01-16 Rodberg James Chief Financial Officer Sale 10b5-1 −2,616 $6.62 $17K 151,230
2026-01-06 Rodberg James Chief Financial Officer Sale −594 $7.48 $4K 153,846
2026-01-05 Rodberg James Chief Financial Officer Sale −4,405 $7.82 $34K 154,440
2025-12-02 Rodberg James Chief Financial Officer Sale −2,518 $8.25 $21K 158,845
2025-11-11 Rodberg James Chief Financial Officer Grant or award +15,337 161,363

Page 1 of 1 · 9 trades